TORONTO, March 23, 2021 (GLOBE NEWSWIRE) -- Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company") is pleased to announce it has entered into a ...
Symp2Pass by SmartCone has partnered with the HEPRU in offering the first ever personal advanced COVID screening process using ScentsiBLE, a patent pending smell test process Ottawa, ...
Symp2Pass’s thermal scanning capabilities allow scans to be completed with an accuracy of ± 0.54° Farenheit and can scan up to 30 people at a distance of more than nine feet, it added. With ...
Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...
The comprehensive system, currently being tested by Ontario Tech University and its partners as part of the contract, will increase safety for employees and site visitors to carry out work ...
Symp2Pass by SmartCone has partnered with the HEPRU in offering the first ever personal advanced COVID screening process using ScentsiBLE, a patent pending smell test process Ottawa, ...
(“Predictmedix” or the “Company”) is pleased to announce it has entered into a letter of intent (the “LOI”), to acquire Symp2Pass Inc. (“Symp2pass”) (the “Acquisition”). The LOI was executed on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results